Filing Details

Accession Number:
0001209191-18-031194
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-17 19:29:28
Reporting Period:
2018-05-15
Accepted Time:
2018-05-17 19:29:28
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1340652 Chemocentryx Inc. CCXI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1226064 M Susan Kanaya C/O Chemocentryx, Inc.
850 Maude Avenue
Mountain View CA 94043
Evp, Cfo And Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-15 8,306 $6.00 46,441 No 4 M Direct
Common Stock Disposition 2018-05-15 8,306 $11.14 38,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-05-16 8,306 $0.00 8,306 $6.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2008-09-10 2018-09-10 No 4 M Direct
Footnotes
  1. Shares sold are associated with stock options that will expire in September 2018.
  2. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  3. Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $11.00 to $11.29 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
  4. As of May 15, 2018, and prior to this transaction, the exercised options were fully vested
  5. Not applicable.